1.45BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00650F1093
CUSIP
00650F109
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.25
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.95
Wall Street Target Price
11.14
EPS Estimate Current Year
-0.84
EPS Estimate Next Year
-0.61
EPS Estimate Current Quarter
-0.31
EPS Estimate Next Quarter
-0.2533
Most Recent Quarter
-
Revenue TTM
189,527,008
Gross Profit TTM
101,438,000
EBITDA
-117,413,000
Profit Margin
-74.84%
Return On Assets TTM
-15.05%
Return On Equity TTM
-61.03%
Revenue Per Share TTM
1.281
Qtly Revenue Growth YOY
25.20%
Diluted Eps TTM
-0.95
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
7.9675
Price Book MRQ
7.93
Enterprise Value Revenue
7
Enterprise Value EBITDA
0
162.19
6.58%258.27
2.78%305.31
0.55%446.80
0.07%0.00
0.00%179.39
0.00%90.68
-2.58%79.74
-1.56%484.93
-0.60%573.50
-0.54%